\
&
Contact us
\
&
Contact us
This cluster encompasses the transition to greenhouse gas neutrality of the energy and mobility sectors by 2050 at the latest. While most calls are about creating a more sustainable environment, there is also attention for other topics like safety in transport or digitization of the energy and mobility sector. These objectives take shape through 6 destinations:
As an integral part of Horizon Europe, a set of EU Missions aims to deliver solutions to some of the greatest challenges facing Europe. Notably two missions (adaptation to climate change + climate neutral and smart cities) are linked to cluster 5 as they both strive to achieve the same objective of a more climate-friendly industry and society.
The New European Bauhaus also merits to be mentioned in this respect as it focuses on a more esthetic, inclusive and sustainable way of construction.
Areas of activity
fernanda.werneck@vlaio.be
+32 2 553 02 62
pascal.verheye@vlaio.be
+32 2 553 09 84
Ria.debreucker@vlaio.be
+32 2 553 13 77
Digital, Industry & Space Climate, Energy, Mobility
The Clean Aviation Joint Undertaking is the European Union’s leading research and innovation programme for transforming aviation towards a sustainable and climate-neutral future. It is a European public-private partnership. Clean Aviation is launching its Third Call for Proposals, calling for innovators and stakeholders across... read more
Digital, Industry & Space Climate, Energy, Mobility
Health Digital, Industry & Space Climate, Energy, Mobility
Health Climate, Energy, Mobility Agro-Food, Environment Missions
Partnerships unite the EC and private and/or public partners to work together in a specific domain. They offer often a good ecosystem to find collaborations.
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
